{"id":791442,"date":"2024-12-02T07:36:14","date_gmt":"2024-12-02T12:36:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/"},"modified":"2024-12-02T07:36:14","modified_gmt":"2024-12-02T12:36:14","slug":"altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/","title":{"rendered":"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders"},"content":{"rendered":"
\n

GAITHERSBURG, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc.<\/a> (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present body composition data from the Phase 2 MOMENTUM trial of pemvidutide in the treatment of obesity and participate in a panel discussion at the Cachexia Regulatory & Trials Update Workshop of the 17th<\/sup> International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders in Washington, D.C.\u00a0\u00a0<\/p>\n

Details for the panel discussion are as follows:<\/p>\n\n\n\n\n\n
\n Title:<\/strong>\n <\/td>\nMuscle Wasting in Weight Loss Therapy<\/td>\n<\/tr>\n
\n Session:<\/strong>\n <\/td>\nTreatment Approaches to Address Muscle Wasting in the Context of Obesity Therapy & Regulatory Issues<\/td>\n<\/tr>\n
\n Presenter:<\/strong>\n <\/td>\nScott Harris, M.D., Chief Medical Officer, Altimmune, Inc.<\/td>\n<\/tr>\n
\n Date\/Time:<\/strong>\n <\/td>\nFriday, December 6, 2024 at 9:30 am ET<\/td>\n<\/tr>\n<\/table>\n

\n About Altimmune<\/strong>\n <\/p>\n

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1\/glucagon dual receptor agonist for the treatment of obesity and MASH.\u00a0 For more information, please visit www.altimmune.com<\/a>.\u00a0<\/p>\n

\n Follow @Altimmune, Inc. on <\/strong>
\n
\n LinkedIn<\/strong>
\n <\/a>
\n
\n Follow @AltimmuneInc on <\/strong>
\n
\n Twitter<\/strong>
\n <\/a>\n <\/p>\n

\n Company Contact:<\/strong>
\n
Greg Weaver
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com<\/a><\/p>\n

\n Investor Contact:<\/strong>
\n
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com<\/a><\/p>\n

\n Media Contact:<\/strong>
\n
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com<\/a><\/p>\n

This press release was published by a CLEAR\u00ae Verified individual.<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

GAITHERSBURG, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present body composition data from the Phase 2 MOMENTUM trial of pemvidutide in the treatment of obesity and participate in a panel discussion at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders in Washington, D.C.\u00a0\u00a0 Details for the panel discussion are as follows: Title: Muscle Wasting in Weight Loss Therapy Session: Treatment Approaches to Address Muscle Wasting in the Context of Obesity Therapy & Regulatory Issues Presenter: Scott Harris, M.D., Chief Medical Officer, Altimmune, Inc. Date\/Time: Friday, December 6, … <\/p>\n

Continue reading “Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-791442","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAltimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present body composition data from the Phase 2 MOMENTUM trial of pemvidutide in the treatment of obesity and participate in a panel discussion at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders in Washington, D.C.\u00a0\u00a0 Details for the panel discussion are as follows: Title: Muscle Wasting in Weight Loss Therapy Session: Treatment Approaches to Address Muscle Wasting in the Context of Obesity Therapy & Regulatory Issues Presenter: Scott Harris, M.D., Chief Medical Officer, Altimmune, Inc. Date\/Time: Friday, December 6, … Continue reading "Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-02T12:36:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders\",\"datePublished\":\"2024-12-02T12:36:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/\"},\"wordCount\":240,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/\",\"name\":\"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=\",\"datePublished\":\"2024-12-02T12:36:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/","og_locale":"en_US","og_type":"article","og_title":"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders - Market Newsdesk","og_description":"GAITHERSBURG, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present body composition data from the Phase 2 MOMENTUM trial of pemvidutide in the treatment of obesity and participate in a panel discussion at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders in Washington, D.C.\u00a0\u00a0 Details for the panel discussion are as follows: Title: Muscle Wasting in Weight Loss Therapy Session: Treatment Approaches to Address Muscle Wasting in the Context of Obesity Therapy & Regulatory Issues Presenter: Scott Harris, M.D., Chief Medical Officer, Altimmune, Inc. Date\/Time: Friday, December 6, … Continue reading \"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-02T12:36:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders","datePublished":"2024-12-02T12:36:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/"},"wordCount":240,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/","name":"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=","datePublished":"2024-12-02T12:36:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA2NSM2NjE2OTYxIzIwMTA2NzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-the-cachexia-regulatory-trials-update-workshop-of-the-17th-international-conference-of-the-society-on-sarcopenia-cachexia-wasting-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/791442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=791442"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/791442\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=791442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=791442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=791442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}